SCHEDULE: Forager Capital Boosts Viemed Healthcare Stake to 7.2%
Beneficial Ownership Report
Forager Capital Management and affiliates disclose 7.2% beneficial ownership in Viemed Healthcare, Inc.
Summary
- Forager Capital Management, LLC, Forager Fund, L.P., Edward Kissel, and Robert MacArthur (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Viemed Healthcare, Inc.
- The Reporting Persons collectively beneficially own 2,736,472 shares of Viemed Healthcare, Inc. common stock.
- This ownership represents 7.2% of the issuer's common stock outstanding.
- The percentage is calculated based on 38,017,907 shares of common stock issued and outstanding as of October 31, 2025, as reported in Viemed Healthcare, Inc.'s Quarterly Report on Form 10-Q filed with the SEC on November 5, 2025.
- Forager Capital Management, LLC and Forager Fund, L.P. each hold sole voting and dispositive power over 2,736,472 shares.
- Edward Kissel and Robert MacArthur each hold shared voting and dispositive power over 2,736,472 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an institutional investor, indicating a significant, passive stake in Viemed Healthcare, Inc. It does not provide specific insights into broader industry trends or competitive positioning beyond the investor's confidence in the company.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake (7.2%) by Forager Capital Management and its affiliates may be viewed positively, signaling investor confidence in Viemed Healthcare, Inc.
Key Dates
| Date | Description |
|---|---|
| July 1, 2025 | Date of Joint Filing Agreement among the reporting persons. |
| September 30, 2025 | Date of event which required the filing of this statement. |
| October 31, 2025 | Date as of which 38,017,907 shares of Common Stock were reported outstanding by the Issuer. |
| November 5, 2025 | Date Viemed Healthcare, Inc. filed its Quarterly Report on Form 10-Q. |
| November 7, 2025 | Date of signing for the Schedule 13G/A by the Reporting Persons. |
Keywords
Viemed Healthcare, Forager Capital Management, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, Healthcare Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.